Brian J. Werth

1.8k total citations
49 papers, 1.4k citations indexed

About

Brian J. Werth is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Brian J. Werth has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 14 papers in Epidemiology and 12 papers in Pharmacology. Recurrent topics in Brian J. Werth's work include Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Brian J. Werth is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Brian J. Werth collaborates with scholars based in United States, Switzerland and Tanzania. Brian J. Werth's co-authors include Michael J. Rybak, George Sakoulas, Katie E. Barber, Susan M. Butler‐Wu, Stephen J. Salipante, Adam Waalkes, Robert M. Rakita, Poochit Nonejuie, Libin Xu and Joe Pogliano and has published in prestigious journals such as Clinical Infectious Diseases, Gut and Journal of Clinical Microbiology.

In The Last Decade

Brian J. Werth

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian J. Werth United States	25	815	488	320	318	294	49	1.4k
John Mohr United States	21	721 0.9×	369 0.8×	472 1.5×	378 1.2×	234 0.8×	49	1.5k
Pamela Moise United States	19	1.2k 1.5×	749 1.5×	522 1.6×	440 1.4×	286 1.0×	38	1.6k
Patricia A. Hogan United States	17	826 1.0×	525 1.1×	312 1.0×	185 0.6×	330 1.1×	24	1.2k
L. A. McDermott United States	21	648 0.8×	497 1.0×	410 1.3×	236 0.7×	195 0.7×	54	1.4k
Esteban C. Nannini United States	18	814 1.0×	332 0.7×	375 1.2×	276 0.9×	223 0.8×	32	1.2k
Wendy Munckhof Australia	20	1.0k 1.3×	635 1.3×	491 1.5×	395 1.2×	300 1.0×	42	1.7k
Lois M. Ednie United States	24	717 0.9×	324 0.7×	499 1.6×	494 1.6×	243 0.8×	49	1.3k
Deborah C. Draghi United States	22	783 1.0×	546 1.1×	513 1.6×	447 1.4×	362 1.2×	33	1.9k
Molly E. Steed United States	18	650 0.8×	363 0.7×	341 1.1×	315 1.0×	143 0.5×	29	959
Chris M. Pillar United States	23	623 0.8×	291 0.6×	287 0.9×	484 1.5×	341 1.2×	45	1.4k

Countries citing papers authored by Brian J. Werth

Since Specialization

Citations

This map shows the geographic impact of Brian J. Werth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Werth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Werth more than expected).

Fields of papers citing papers by Brian J. Werth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian J. Werth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Werth. The network helps show where Brian J. Werth may publish in the future.

Co-authorship network of co-authors of Brian J. Werth

This figure shows the co-authorship network connecting the top 25 collaborators of Brian J. Werth. A scholar is included among the top collaborators of Brian J. Werth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian J. Werth. Brian J. Werth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Werth, Brian J., Rutan Zhang, Kelsi Penewit, et al.. (2025). Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effect with other antimicrobials. Journal of Antimicrobial Chemotherapy. 80(4). 1108–1115.

Werth, Brian J., Thomas J. Dilworth, Alan E. Gross, et al.. (2022). Reporting behaviors and perceptions toward the National Healthcare Safety Network antimicrobial use (AU) and antimicrobial resistance (AR) modules. Infection Control and Hospital Epidemiology. 44(3). 406–412. 1 indexed citations

Shen, Tianwei, et al.. (2021). Varied Contribution of Phospholipid Shedding From Membrane to Daptomycin Tolerance in Staphylococcus aureus. Frontiers in Molecular Biosciences. 8. 679949–679949. 5 indexed citations

Zhang, Rutan, Kelsi Penewit, Adam Waalkes, et al.. (2021). Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus. Frontiers in Molecular Biosciences. 8. 688357–688357. 7 indexed citations

Barbee, Lindley A., et al.. (2020). "Sex in the time of COVID": clinical guidelines for STD management in an era of social distancing. Sexually Transmitted Diseases. 1 indexed citations

Werth, Brian J., Kelsi Penewit, Adam Waalkes, et al.. (2020). Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection. 27(6). 910.e1–910.e8. 32 indexed citations

Mbwasi, Romuald, Rachel Wittenauer, Richard Valimba, et al.. (2020). National Consumption of Antimicrobials in Tanzania: 2017–2019. Frontiers in Pharmacology. 11. 585553–585553. 35 indexed citations

Theuretzbacher, Ursula, Lindley A. Barbee, Kristie L. Connolly, et al.. (2020). Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities. Clinical Microbiology and Infection. 26(12). 1630–1635. 15 indexed citations

Hines, Kelly M., Tianwei Shen, Adam Waalkes, et al.. (2019). Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels. Journal of Antimicrobial Chemotherapy. 75(5). 1182–1186. 33 indexed citations

10.

Werth, Brian J., Rupali Jain, Lisa A. Cummings, et al.. (2017). Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen. Clinical Microbiology and Infection. 24(4). 429.e1–429.e5. 71 indexed citations

11.

Werth, Brian J., Poochit Nonejuie, John P. McRoberts, et al.. (2016). Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 60(10). 5716–5723. 33 indexed citations

12.

Werth, Brian J., Joseph J. Carreno, & Kelly R. Reveles. (2015). Shifting trends in the incidence of Pseudomonas aeruginosa septicemia in hospitalized adults in the United States from 1996-2010. American Journal of Infection Control. 43(5). 465–468. 12 indexed citations

13.

Werth, Brian J., Won-Ho Hahn, Susan M. Butler‐Wu, & Robert M. Rakita. (2015). Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections. Microbial Drug Resistance. 22(3). 233–237. 37 indexed citations

14.

Barber, Katie E., Brian J. Werth, & Michael J. Rybak. (2014). The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA. Journal of Antimicrobial Chemotherapy. 70(2). 505–509. 37 indexed citations

15.

Snyder, Ashley H., Brian J. Werth, Katie E. Barber, George Sakoulas, & Michael J. Rybak. (2014). Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. Journal of Antimicrobial Chemotherapy. 69(8). 2148–2154. 46 indexed citations

16.

Barber, Katie E., Brian J. Werth, Poochit Nonejuie, et al.. (2014). Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes. Journal of Antimicrobial Chemotherapy. 69(11). 3006–3010. 50 indexed citations

17.

Ortwine, Jessica K., Brian J. Werth, George Sakoulas, & Michael J. Rybak. (2013). Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the “seesaw effect”: Taking advantage of the back door left open?. Drug Resistance Updates. 16(3-5). 73–79. 49 indexed citations

18.

Werth, Brian J., George Sakoulas, Warren E. Rose, et al.. (2012). Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 57(1). 66–73. 111 indexed citations

19.

Werth, Brian J., et al.. (1993). [Drug-induced liver disease: experiences of the Swiss Center for Adverse Drug Effects 1989-1991].. PubMed. 123(23). 1203–6. 2 indexed citations

20.

Werth, Brian J., Christoph Beglinger, Jürgen Drewe, et al.. (1991). Helicobacter pylori infection in healthy people: a dynamic process?. Gut. 32(4). 347–350. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact